The questions that tend to come next.

Is this a real substance?

Yes. Thymosin alpha-1 is a peptide: a few protein building blocks joined together. Thymalfasin names the medicine form made in a lab.

• The next question is what a proposed use has been shown to do.

Can a U.S. prescription settle the access question?

No. The check dated September 28, 2026 found no U.S. product with FDA approval. Thymosin alpha-1 also did not satisfy the ingredient conditions for pharmacies preparing an identified patient’s medicine.

The FDA is the U.S. drug review agency.

• Ask to see the U.S. approval record for the medicine, or the ingredient rule that permits the pharmacy to make it. Ask for the care plan too.

Has it been shown to boost immunity?

The FDA review describes possible effects on the body’s defence cells.

An effect on cells is not proof of a health benefit.

• Ask which result in people supports the specific goal you have.

Does every visit require blood tests?

No general federal rule made blood testing a requirement for all prescriptions as of September 26, 2026. Federal means a rule for the whole United States.

That general rule does not answer whether you need tests for this medicine. Some medicines have their own test requirements. State rules and your health assessment also matter.

• Ask what a proposed test would help decide.

What is a fair price?

There was no official U.S. maker’s price for thymosin alpha-1 to report as of September 28, 2026.

• Ask for a written quote that lists each charge, including what you will pay later.
• Read the cost note before comparing offers.

Does a missing sports-list entry mean it is permitted?

No. Records checked September 28, 2026 found no named entry for thymosin alpha-1 in the World Anti-Doping Agency’s lists.

Even if the name is missing, other parts of the sports rules may still forbid its use.

• Ask the organisation that enforces your sport’s drug rules for a decision on the exact ingredient.